Pharmacist Intervention for Safer Prescribing in Patients With Type 2 Diabetes at High Risk

Does proactive outreach by a clinical pharmacist applying an evidence-based hypoglycemia-prevention algorithm result in safer diabetes regimens among patients with type 2 diabetes at high risk of hypoglycemia?In this randomized clinical trial of 200 adults, patients in the intervention arm (proactive outreach by the pharmacist) were statistically significantly more likely to be prescribed a safer diabetes regimen compared with those in the usual care arm (28% vs 16%).The findings of this study suggest that proactive, protocol-driven outreach by clinical pharmacists as part of collaborative team-based care leads to safer diabetes medication prescribing in patients with type 2 diabetes at high risk of hypoglycemia.

Corresponding Author: Lisa K. Gilliam, MD, PhD, The Permanente Medical Group, South San Francisco Kaiser Medical Center, 1200 El Camino Real, South San Francisco, CA 94080 (lisa.k.gilliam@kp.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.